ANDRES MANUEL R
CERVANTES RUIPEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
Massachusetts General Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Massachusetts General Hospital (4)
2023
-
Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer
ESMO Open, Vol. 8, Núm. 2
2020
-
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment
Investigational New Drugs, Vol. 38, Núm. 6, pp. 1774-1783
-
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors
Annals of Oncology, Vol. 31, Núm. 5, pp. 626-633
2019
-
Definition of the rectum: An International, expert-based Delphi consensus
Annals of Surgery, Vol. 270, Núm. 6, pp. 955-959